Market Research Logo

Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report

Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates in the US and Europe. It is headquartered in Salt Lake City, Utah.

Scope

  • Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs.
  • A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis.
  • An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments.
  • Intelligence on Myriad Genetics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
  • News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins.
  • Large number of easy-to-grasp charts and graphs that present important data and key trends.
Reasons to buy
  • Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Myriad Genetics, Inc.'s business structure, strategy and prospects.


Company Snapshot
Myriad Genetics, Inc.: Company Overview
Myriad Genetics, Inc.: Overview and Key Facts
Myriad Genetics, Inc.: Overview
Myriad Genetics, Inc.: Key Facts
Myriad Genetics, Inc.: Key Employees
Myriad Genetics, Inc.: Key Employee Biographies
Myriad Genetics, Inc.: Major Products and Services
Myriad Genetics, Inc.: Company History
Myriad Genetics, Inc.: Management Statement
Myriad Genetics, Inc.: Locations and Subsidiaries
Myriad Genetics, Inc.: Key Competitors
Myriad Genetics, Inc.: Company Analysis
Myriad Genetics, Inc.: Business Description
Myriad Genetics, Inc.: SWOT Analysis
Myriad Genetics, Inc.: SWOT Overview
Myriad Genetics, Inc.: Strengths
Myriad Genetics, Inc.: Weaknesses
Myriad Genetics, Inc.: Opportunities
Myriad Genetics, Inc.: Threats
Myriad Genetics, Inc.: Corporate Financial Deals Activity
Myriad Genetics, Inc.: Financial Deals Overview
Myriad Genetics, Inc.: Targets and Partners
Myriad Genetics, Inc.: Top Deals 2013 - 2017YTD*
Myriad Genetics, Inc.: Mergers and Acquisitions
Myriad Genetics, Inc.: Corporate Venturing
Myriad Genetics, Inc.: Partnership
Myriad Genetics, Inc.: Recent Developments
Myriad Genetics, Inc.: News and Events Summary
Myriad Genetics, Inc.: Contracts
Myriad Genetics, Inc.: Corporate Governance
Myriad Genetics, Inc.: Financial Performance
Myriad Genetics, Inc.: Research & Development
Myriad Genetics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine
List of Tables
Table 1: Myriad Genetics, Inc.: Key Facts
Table 2: Myriad Genetics, Inc.: Key Employees
Table 3: Myriad Genetics, Inc.: Locations and Subsidiaries
Table 4: Myriad Genetics, Inc.: Key Competitors
Table 5: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Myriad Genetics, Inc.: Targets and Partners
Table 9: Myriad Genetics, Inc.: Top Deals 2013 - 2017YTD*
Table 10: Myriad Genetics, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: Myriad Genetics, Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 12: Myriad Genetics, Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 13: Myriad Genetics, Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 14: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 15: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 16: Myriad Genetics, Inc.: News and Events Summary
Table 17: Myriad Genetics, Inc.: Contracts
Table 18: Myriad Genetics, Inc.: Corporate Governance
Table 19: Myriad Genetics, Inc.: Financial Performance
Table 20: Myriad Genetics, Inc.: Research & Development
Table 21: Myriad Genetics, Inc.: Strategy and Operations
List of Figures
Figure 1: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Figure 3: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Myriad Genetics, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Figure 5: Myriad Genetics, Inc.: M&A Activity by Geography (2013 - YTD*2017)
Figure 6: Myriad Genetics, Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Figure 7: Myriad Genetics, Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Figure 8: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Figure 9: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report